IL83377A0 - Nmr imaging with paramagnetic polyvalent metal salts of poly(acid-alkylene-amino)-alkanes - Google Patents

Nmr imaging with paramagnetic polyvalent metal salts of poly(acid-alkylene-amino)-alkanes

Info

Publication number
IL83377A0
IL83377A0 IL83377A IL8337787A IL83377A0 IL 83377 A0 IL83377 A0 IL 83377A0 IL 83377 A IL83377 A IL 83377A IL 8337787 A IL8337787 A IL 8337787A IL 83377 A0 IL83377 A0 IL 83377A0
Authority
IL
Israel
Prior art keywords
paramagnetic
alkanes
alkylene
poly
amino
Prior art date
Application number
IL83377A
Other languages
English (en)
Original Assignee
Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/057,709 external-priority patent/US5039512A/en
Application filed by Salutar Inc filed Critical Salutar Inc
Publication of IL83377A0 publication Critical patent/IL83377A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic System without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
IL83377A 1986-08-04 1987-07-30 Nmr imaging with paramagnetic polyvalent metal salts of poly(acid-alkylene-amino)-alkanes IL83377A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89313686A 1986-08-04 1986-08-04
US90093086A 1986-08-27 1986-08-27
US07/057,709 US5039512A (en) 1986-08-04 1987-06-15 NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes

Publications (1)

Publication Number Publication Date
IL83377A0 true IL83377A0 (en) 1987-12-31

Family

ID=27369315

Family Applications (2)

Application Number Title Priority Date Filing Date
IL83377A IL83377A0 (en) 1986-08-04 1987-07-30 Nmr imaging with paramagnetic polyvalent metal salts of poly(acid-alkylene-amino)-alkanes
IL10121092A IL101210A (en) 1986-08-04 1992-03-12 Use of a paramagnetic polyvalent metal salt of poly-(acid-alkylene-amino)-alkanes and a non-paramagnetic organic calcium salt in the preparation of a composition for nmr imaging

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL10121092A IL101210A (en) 1986-08-04 1992-03-12 Use of a paramagnetic polyvalent metal salt of poly-(acid-alkylene-amino)-alkanes and a non-paramagnetic organic calcium salt in the preparation of a composition for nmr imaging

Country Status (16)

Country Link
EP (2) EP0258616B1 (da)
JP (1) JP2667666B2 (da)
AT (1) ATE138809T1 (da)
AU (1) AU608759B2 (da)
CA (1) CA1321346C (da)
DE (2) DE3777727D1 (da)
DK (1) DK167797B1 (da)
ES (2) ES2030023T3 (da)
FI (1) FI88677C (da)
GR (1) GR3004576T3 (da)
HK (1) HK96597A (da)
IE (1) IE64108B1 (da)
IL (2) IL83377A0 (da)
NO (1) NO173767C (da)
NZ (1) NZ221288A (da)
SG (1) SG78250A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
AU629171B2 (en) * 1987-06-30 1992-10-01 Mallinckrodt, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonants imaging agents and x-ray contrast agents
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
GB8900732D0 (en) * 1989-01-13 1989-03-08 Nycomed As Agents
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
US5516503A (en) * 1989-11-16 1996-05-14 Guerbet S.A. Diagnostic composition comprising a binuclear complex, its method of preparation and its use in magnetic resonance imaging
FR2654344B1 (fr) * 1989-11-16 1994-09-23 Cis Bio Int Complexe paramagnetique de gadolinium, son procede de preparation et son utilisation pour le diagnostic par irm.
JP2593963B2 (ja) * 1989-11-27 1997-03-26 コンキャット リミティド 常磁性カチオン及びポリホスホネートリガンドの錯体を用いての骨及び関連組織のｍｒｉ像増強
US5236695A (en) * 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
DE4011684A1 (de) 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
US5843399A (en) * 1990-04-06 1998-12-01 Schering Aktiengesellschaft DTPA monoamides for MRI
US5562894A (en) * 1991-08-09 1996-10-08 Regents Of The University Of California Amino-acyl-type and catecholamine-type contrast agents for MRI
IT1252145B (it) * 1991-11-29 1995-06-05 Bracco Ind Chimica Spa Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
DE4302287A1 (de) * 1993-01-25 1994-07-28 Schering Ag Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
US5409689A (en) * 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US5476644A (en) * 1994-04-13 1995-12-19 Sterling Winthrop Inc. Cyclic triamine chelating agents
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
TW319763B (da) 1995-02-01 1997-11-11 Epix Medical Inc
US5874573A (en) 1995-06-26 1999-02-23 Concat, Inc. Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy
IT1297035B1 (it) 1997-12-30 1999-08-03 Bracco Spa Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
US5980863A (en) * 1998-11-02 1999-11-09 Eagle Vision Pharmaceutical Corporation Manganese compositions and methods for MRI
AU5871000A (en) 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
JP2007062462A (ja) * 2005-08-30 2007-03-15 Nifco Inc 多用途収容装置
US8378134B2 (en) 2009-09-30 2013-02-19 General Electric Company Hydroxylated contrast enhancement agents
NO331773B1 (no) 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
EP2988756B2 (fr) 2013-04-26 2022-05-18 Guerbet Formulation de produit de contraste et son procede de preparation associe
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
US10730897B2 (en) 2016-12-21 2020-08-04 Ge Healthcare As Manganese chelate compounds
JP7332600B2 (ja) 2017-12-20 2023-08-23 ゼネラル・エレクトリック・カンパニイ アニオン性キレート化合物
GB201919073D0 (en) 2019-12-20 2020-02-05 Ge Healthcare As Novel manufacturing process

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818061A (en) * 1971-11-09 1974-06-18 Merck Sharp & Dohme Transparent nmr shift reagents
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
CA1242643A (en) * 1983-08-12 1988-10-04 Eric T. Fossel Nmr imaging utilizing chemical shift reagents
US4749560A (en) * 1984-08-13 1988-06-07 Research Corporation Metal organo phosphorous compounds for NMR analysis
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
AU629171B2 (en) * 1987-06-30 1992-10-01 Mallinckrodt, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonants imaging agents and x-ray contrast agents

Also Published As

Publication number Publication date
ATE138809T1 (de) 1996-06-15
EP0258616A1 (en) 1988-03-09
GR3004576T3 (da) 1993-04-28
NO173767B (no) 1993-10-25
IE872076L (en) 1988-02-04
ES2087938T3 (es) 1996-08-01
EP0463644A3 (en) 1992-11-19
DK401087A (da) 1988-02-05
FI88677C (fi) 1993-06-28
NO873237D0 (no) 1987-08-03
AU608759B2 (en) 1991-04-18
AU7573587A (en) 1988-02-11
ES2030023T3 (es) 1992-10-16
NO873237L (no) 1988-02-05
CA1321346C (en) 1993-08-17
SG78250A1 (en) 2001-02-20
FI873382A0 (fi) 1987-08-04
HK96597A (en) 1997-08-08
DE3751829D1 (de) 1996-07-11
DK401087D0 (da) 1987-07-31
IL101210A (en) 1996-10-31
NZ221288A (en) 1990-10-26
FI873382A (fi) 1988-02-05
EP0258616B1 (en) 1992-03-25
JPS63119446A (ja) 1988-05-24
NO173767C (no) 1994-02-02
EP0463644A2 (en) 1992-01-02
JP2667666B2 (ja) 1997-10-27
DE3777727D1 (de) 1992-04-30
FI88677B (fi) 1993-03-15
EP0463644B1 (en) 1996-06-05
DK167797B1 (da) 1993-12-20
DE3751829T2 (de) 1996-10-31
IE64108B1 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
IL83377A0 (en) Nmr imaging with paramagnetic polyvalent metal salts of poly(acid-alkylene-amino)-alkanes
HK130797A (en) Novel magnetic resonance imaging agents
ZA882552B (en) Nitrogen-containing cyclic ligands,metallic complexes formed by these ligands,diagnostic compositions containing these complexes and process for the preparation of the ligands
NZ236162A (en) Cascade polymers containing complex-forming ligands and their use as nmr and x-ray contrast agents
IL106164A0 (en) Polyazamacrocyclic compounds and their complexes with metal ions
DE69116637T2 (de) Mittel zur magnetischen Resonanzabbildung
EP0230027A3 (en) Magnet shimming using information derived from chemical shift imaging
DE69100842D1 (de) Unlösliche salze von lanthaniden zur bildlichen darstellung des magen-darmtrakts mittels nuklearmagnetischer resonanz.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired